Patients with sickle cell disease taking hydroxyurea in the Hemocentro Regional de Montes Claros

about

Patients with sickle cell disease taking hydroxyurea in the Hemocentro Regional de Montes Claros

Item

http://www.wikidata.org/entity/Q36462461

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Patients with sickle cell dise ...... ntro Regional de Montes Claros

@ast

Patients with sickle cell dise ...... ntro Regional de Montes Claros

@en

type

Item

label

Patients with sickle cell dise ...... ntro Regional de Montes Claros

@ast

Patients with sickle cell dise ...... ntro Regional de Montes Claros

@en

prefLabel

Patients with sickle cell dise ...... ntro Regional de Montes Claros

@ast

Patients with sickle cell dise ...... ntro Regional de Montes Claros

@en

P1476

Patients with sickle cell dise ...... ntro Regional de Montes Claros

@en

P2093

Caroline Nogueira Maia

http://www.w3.org/2001/XMLSchema#string

Fernanda Kelle de Souza Santos

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia.

Nitric oxide therapy in sickle cell disease.

New Views of Sickle Cell Disease Pathophysiology and Treatment.

The role of hydroxyurea in sickle cell disease.

Established and experimental treatments for sickle cell disease.

Sickle cell vaso-occlusion.

Blood transfusion in sickle cell disease.

Use of hydroxyurea in children ages 2 to 5 years with sickle cell disease.

Therapy with hydroxyurea is associated with reduced adhesion molecule gene and protein expression in sickle red cells with a concomitant reduction in adhesive properties.

Nitric oxide and cyclic GMP levels in sickle cell patients receiving hydroxyurea.

P304

105-109

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5581/1516-8484.20110029

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234040497

http://www.w3.org/2001/XMLSchema#string

P698

23284256

http://www.w3.org/2001/XMLSchema#string

P921

sickle-cell disease

P932

3520633

http://www.w3.org/2001/XMLSchema#string